This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas



Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

​​​​​Identifying Common Symptoms

Adapted from Tao, et al. 2019

Dostinex (cabergoline) prescribing information can be found here
1.Colao A, Sarno AD, Cappabianca P, et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol. 2003;148(3):325-331.
2.Endocrine Society. The Hormone Foundation's patient guide to hyperprolactinemia diagnosis and treatment. Accessed April 2022.
3. Tao L, Qiao-sheng L, Yuan-jian Y, Bo W. Aripiprazole for the treatment of duloxetine-induced hyperprolactinemia: A case report. J Affect Disord. 2019:330-332.
4. Fedorova NS, Vorotnikova SY, Pigarova EA. Description of clinical portraits of patients with hyperprolactinemia [in Russian]. Obesity & Metabolism. 2018;15:65-69

PP-UNP-GBR-0580. June 2022

Interpreting Test Results

Recognise which tests to order and what the results indicate

Learn more


Selecting Treatment based on Guidelines

Determine therapy based on clinical and patient factors

Learn more

Monitoring and Management

Learn how to tailor therapy based on follow-up testing​​​​​​​

Learn more

What is Hyperprolactinaemia?

See general information including pathophysiology and etiology​​​​​​​

Learn more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021



OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?